A citation-based method for searching scientific literature

Rachel Martini, Lisa Newman, Melissa Davis. Clin Exp Metastasis 2022
Times Cited: 3







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Hereditary Susceptibility for Triple Negative Breast Cancer Associated With Western Sub-Saharan African Ancestry: Results From an International Surgical Breast Cancer Collaborative.
Lisa A Newman, Brittany Jenkins, Yalei Chen, Joseph K Oppong, Ernest Adjei, Aisha S Jibril, Syed Hoda, Esther Cheng, Dhananjay Chitale, Jessica M Bensenhaver,[...]. Ann Surg 2019
27
66

The role of sentinel lymph node mapping in colon cancer: detection of micro-metastasis, effect on survival, and driver of a paradigm shift in extent of colon resection.
Sukamal Saha, Bekele Philimon, Malore Efeson, Abebe Helina, Mohamed Elgamal, Gurmessa Kiya, Suga Hilkiah, Madan Arora, David Wiese, Yoko Kitagawa. Clin Exp Metastasis 2022
5
33

Current management of melanoma patients with nodal metastases.
Dale Han, Alexander C J van Akkooi, Richard J Straker, Adrienne B Shannon, Giorgos C Karakousis, Lin Wang, Kevin B Kim, Douglas Reintgen. Clin Exp Metastasis 2022
3
33

The lymphatic system and sentinel lymph nodes: conduit for cancer metastasis.
Stanley P Leong, Alexander Pissas, Muriel Scarato, Francoise Gallon, Marie Helene Pissas, Miguel Amore, Max Wu, Mark B Faries, Amanda W Lund. Clin Exp Metastasis 2022
4
33

In-transit metastatic cutaneous melanoma: current management and future directions.
Ayushi Patel, Michael J Carr, James Sun, Jonathan S Zager. Clin Exp Metastasis 2022
2
50

1
100


Cancer neoantigens as potential targets for immunotherapy.
Weijie Ma, Brian Pham, Tianhong Li. Clin Exp Metastasis 2022
9
33

Secondary lymphedema from cancer therapy.
Michael Bernas, Saskia R J Thiadens, Paula Stewart, Jay Granzow. Clin Exp Metastasis 2022
3
33

Current status of gastrointestinal tract cancer brain metastasis and the use of blood-based cancer biomarker biopsy.
Yoshiaki Shoji, Satoru Furuhashi, Daniel F Kelly, Anton J Bilchik, Dave S B Hoon, Matias A Bustos. Clin Exp Metastasis 2022
2
50

Mechanisms of breast cancer metastasis.
S David Nathanson, Michael Detmar, Timothy P Padera, Lucy R Yates, Danny R Welch, Thomas C Beadnell, Adam D Scheid, Emma D Wrenn, Kevin Cheung. Clin Exp Metastasis 2022
4
33

Precision oncology for breast cancer through clinical trials.
Aurora S Blucher, Gordon B Mills, Yiu Huen Tsang. Clin Exp Metastasis 2022
2
50

Introduction to novel developments in radio-imaging and radiotherapy.
Baldassarre Stea, Russell S Witte. Clin Exp Metastasis 2022
1
100

Sentinel lymph node biopsy in melanoma: beyond histologic factors.
Michael J Carr, Federico A Monzon, Jonathan S Zager. Clin Exp Metastasis 2022
3
33

Epigenetic changes in cancer.
Christine A Iacobuzio-Donahue. Annu Rev Pathol 2009
120
33


Cancer heterogeneity and metastasis: life at the edge.
Robert J Gillies. Clin Exp Metastasis 2022
10
33

Molecular mechanisms of cancer metastasis via the lymphatic versus the blood vessels.
Stanley P Leong, Kamila Naxerova, Laura Keller, Klaus Pantel, Marlys Witte. Clin Exp Metastasis 2022
7
33

Cancer microenvironment and genomics: evolution in process.
Stanley P Leong, Isaac P Witz, Orit Sagi-Assif, Sivan Izraely, Jonathan Sleeman, Brian Piening, Bernard A Fox, Carlo B Bifulco, Rachel Martini, Lisa Newman,[...]. Clin Exp Metastasis 2022
2
50

Darwin's clinical relevance.
S Hellman. Cancer 1997
22
33

Detection of cancer metastasis: past, present and future.
Catherine Alix-Panabieres, Anthony Magliocco, Luis Enrique Cortes-Hernandez, Zahra Eslami-S, Daniel Franklin, Jane L Messina. Clin Exp Metastasis 2022
2
50

Novel frontiers in detecting cancer metastasis.
Stanley P Leong, Carmen Ballesteros-Merino, Shawn M Jensen, Sebastian Marwitz, Carlo Bifulco, Bernard A Fox, Mojca Skoberne. Clin Exp Metastasis 2018
6
33

Tumor Mutation Burden: Leading Immunotherapy to the Era of Precision Medicine?
Conor E Steuer, Suresh S Ramalingam. J Clin Oncol 2018
97
33

Editorial.
Stanley P Leong, Jonathan S Zager. Clin Exp Metastasis 2018
1
100


Immunotherapy of cancer in the era of checkpoint inhibitor.
Inderjit Mehmi, Omid Hamid. Clin Exp Metastasis 2022
1
100


Bringing precision oncology to cellular resolution with single-cell genomics.
Yuntao Xia, Charles Gawad. Clin Exp Metastasis 2022
1
100

Abrupt involution induces inflammation, estrogenic signaling, and hyperplasia linking lack of breastfeeding with increased risk of breast cancer.
Mustafa M Basree, Neelam Shinde, Christopher Koivisto, Maria Cuitino, Raleigh Kladney, Jianying Zhang, Julie Stephens, Marilly Palettas, Allen Zhang, Hee Kyung Kim,[...]. Breast Cancer Res 2019
26
33

Seviteronel, a Novel CYP17 Lyase Inhibitor and Androgen Receptor Antagonist, Radiosensitizes AR-Positive Triple Negative Breast Cancer Cells.
Anna R Michmerhuizen, Benjamin Chandler, Eric Olsen, Kari Wilder-Romans, Leah Moubadder, Meilan Liu, Andrea M Pesch, Amanda Zhang, Cassandra Ritter, S Tanner Ward,[...]. Front Endocrinol (Lausanne) 2020
15
33

Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer.
Amelia A Peters, Grant Buchanan, Carmela Ricciardelli, Tina Bianco-Miotto, Margaret M Centenera, Jonathan M Harris, Shalini Jindal, Davendra Segara, Li Jia, Nicole L Moore,[...]. Cancer Res 2009
274
33

Epigenetic Determinants of Racial Disparity in Breast Cancer: Looking beyond Genetic Alterations.
Shriya Joshi, Chakravarthy Garlapati, Ritu Aneja. Cancers (Basel) 2022
5
33

Acentrosomal spindle organization renders cancer cells dependent on the kinesin HSET.
Julia Kleylein-Sohn, Bernadette P├Âllinger, Michaela Ohmer, Francesco Hofmann, Erich A Nigg, Brian A Hemmings, Markus Wartmann. J Cell Sci 2012
74
33

Genome-wide methylation patterns provide insight into differences in breast tumor biology between American women of African and European ancestry.
Christine B Ambrosone, Allyson C Young, Lara E Sucheston, Dan Wang, Li Yan, Song Liu, Li Tang, Qiang Hu, Jo L Freudenheim, Peter G Shields,[...]. Oncotarget 2014
45
33

KIFC1 is a novel potential therapeutic target for breast cancer.
Yonghe Li, Wenyan Lu, Dongquan Chen, Rebecca J Boohaker, Ling Zhai, Indira Padmalayam, Krister Wennerberg, Bo Xu, Wei Zhang. Cancer Biol Ther 2015
55
33

Approach to the Triple Negative Breast Cancer in New Drugs Area.
Mehrzad Mirzania. Int J Hematol Oncol Stem Cell Res 2016
17
33

AR negative triple negative or "quadruple negative" breast cancers in African American women have an enriched basal and immune signature.
Melissa Davis, Shweta Tripathi, Raymond Hughley, Qinghua He, Sejong Bae, Balasubramanyam Karanam, Rachel Martini, Lisa Newman, Windy Colomb, William Grizzle,[...]. PLoS One 2018
30
33

Androgen receptor levels and association with PIK3CA mutations and prognosis in breast cancer.
Ana M Gonzalez-Angulo, Katherine Stemke-Hale, Shana L Palla, Mark Carey, Roshan Agarwal, Funda Meric-Berstam, Tiffany A Traina, Clifford Hudis, Gabriel N Hortobagyi, William L Gerald,[...]. Clin Cancer Res 2009
157
33

ARN-509: a novel antiandrogen for prostate cancer treatment.
Nicola J Clegg, John Wongvipat, James D Joseph, Chris Tran, Samedy Ouk, Anna Dilhas, Yu Chen, Kate Grillot, Eric D Bischoff, Ling Cai,[...]. Cancer Res 2012
441
33

Triple-negative breast cancer: clinical features and patterns of recurrence.
Rebecca Dent, Maureen Trudeau, Kathleen I Pritchard, Wedad M Hanna, Harriet K Kahn, Carol A Sawka, Lavina A Lickley, Ellen Rawlinson, Ping Sun, Steven A Narod. Clin Cancer Res 2007
33

The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parameters.
V Kuenen-Boumeester, T H Van der Kwast, C C Claassen, M P Look, G S Liem, J G Klijn, S C Henzen-Logmans. Eur J Cancer 1996
127
33

Breast cancer molecular subtypes: from TNBC to QNBC.
Jane Date C Hon, Baljit Singh, Aysegul Sahin, Gang Du, Jinhua Wang, Vincent Y Wang, Fang-Ming Deng, David Y Zhang, Marie E Monaco, Peng Lee. Am J Cancer Res 2016
96
33

Tackling intra- and inter-tumor heterogeneity to combat triple negative breast cancer.
Nikita Wright, Padmashree C G Rida, Ritu Aneja. Front Biosci (Landmark Ed) 2017
9
33


Targeting risk factors for reducing the racially disparate burden in breast cancer.
Nikita Wright, Tomi Akinyemiju, Preeti Subhedar, Padmashree Rida, Ritu Aneja. Front Biosci (Schol Ed) 2019
7
33

Stratification of Prognosis of Triple-Negative Breast Cancer Patients Using Combinatorial Biomarkers.
Yong Yue, Kristine Astvatsaturyan, Xiaojiang Cui, Xiao Zhang, Benedick Fraass, Shikha Bose. PLoS One 2016
18
33

Long chain fatty Acyl-CoA synthetase 4 is a biomarker for and mediator of hormone resistance in human breast cancer.
Xinyu Wu, Yirong Li, Jinhua Wang, Xin Wen, Max T Marcus, Garrett Daniels, David Y Zhang, Fei Ye, Ling Hang Wang, Xinxin Du,[...]. PLoS One 2013
58
33

The role of androgens in mammary carcinogenesis.
Y C Wong, B Xie. Ital J Anat Embryol 2001
25
33

Triple-negative breast cancer in African-American women: disparities versus biology.
Eric C Dietze, Christopher Sistrunk, Gustavo Miranda-Carboni, Ruth O'Regan, Victoria L Seewaldt. Nat Rev Cancer 2015
240
33

Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast Cancer.
Tiffany A Traina, Kathy Miller, Denise A Yardley, Janice Eakle, Lee S Schwartzberg, Joyce O'Shaughnessy, William Gradishar, Peter Schmid, Eric Winer, Catherine Kelly,[...]. J Clin Oncol 2018
235
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.